Head-to-head · WeighScore
BiltRx vs JRNYS
By GLP-1 ScorecardUpdated
Score comparison
BiltRx has the higher recorded score — 75.3/100 to 62.5/100.
BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.
Before you choose
JRNYS does not publish a semaglutide price, so its JRNYS review sets out what it does disclose, while the BiltRx review explains the conditions attached to BiltRx's figure. The semaglutide cost page compares published rates across the field. Ask JRNYS for a written total before treating either one as the cheaper choice.
If neither one fits, BiltRx vs LifespanningRx and CoreAge Rx vs JRNYS compare each of them with another graded program, and the list of alternatives to BiltRx ranks the programs closest to BiltRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | BiltRx | JRNYS |
|---|---|---|
| WeighScore | 75.3/100 | 62.5/100 |
| Grade | C | C |
| Site position | #59 | #290 |
| Semaglutide | $82/mo advertised medication starting price; confirm care and shipping charges | Not disclosed |
| Tirzepatide | $130/mo advertised medication starting price; confirm care and shipping charges | Tirzepatide microdose from $216/mo; membership from $89/mo may be separate (compounded) |
| Coverage | All 50 states advertised | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes 12-week package totals
- Explains the consultation charge if treatment is declined
What to consider
- Confirm whether consultation and shipping are included in the selected plan
- Renewal cancellation does not refund an approved order
Strengths
- Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
- The membership band is published before intake and is banded openly by level of coach support
- Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
- Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
- Members with commercial insurance may pay around $25 a month for the medication after any deductible
What to consider
- The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
- No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
- The best case depends on commercial insurance coverage; without it the medication cost is unknown
- No compounded option is disclosed — the program is brand-focused, and brand list prices are the dearest route to a GLP-1
- The states it can prescribe in are not published
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.